Analyses revealed that the result of this study was promising and therefore the study was continued to a second part using second generation of improved NGF releasing device containing polyethylene terephthalate (PET) yarn in additional 4 AD patients for 6 months of implantation (Eyjolfsdottir et al., 2016). This evidence concerns the gene NGF and Alzheimer disease.